3.59
price down icon6.02%   -0.23
after-market Dopo l'orario di chiusura: 3.59
loading
Precedente Chiudi:
$3.82
Aprire:
$3.8
Volume 24 ore:
637.23K
Relative Volume:
0.64
Capitalizzazione di mercato:
$210.35M
Reddito:
-
Utile/perdita netta:
$-117.81M
Rapporto P/E:
-1.9096
EPS:
-1.88
Flusso di cassa netto:
$74.30M
1 W Prestazione:
+3.16%
1M Prestazione:
+6.21%
6M Prestazione:
-57.11%
1 anno Prestazione:
-34.13%
Intervallo 1D:
Value
$3.58
$3.87
Intervallo di 1 settimana:
Value
$3.34
$3.87
Portata 52W:
Value
$2.95
$13.60

Omeros Corporation Stock (OMER) Company Profile

Name
Nome
Omeros Corporation
Name
Telefono
206-676-5000
Name
Indirizzo
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Name
Dipendente
202
Name
Cinguettio
@OmerosCorp
Name
Prossima data di guadagno
2025-03-31
Name
Ultimi documenti SEC
Name
OMER's Discussions on Twitter

Confronta OMER con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
OMER
Omeros Corporation
3.59 223.82M 0 -117.81M 74.30M -1.88
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Omeros Corporation Stock (OMER) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-10 Iniziato H.C. Wainwright Buy
2024-12-23 Iniziato D. Boral Capital Buy
2024-11-14 Iniziato Rodman & Renshaw Buy
2022-12-08 Downgrade UBS Buy → Neutral
2022-11-08 Downgrade BofA Securities Neutral → Underperform
2022-06-08 Downgrade BofA Securities Buy → Neutral
2021-10-08 Downgrade JP Morgan Neutral → Underweight
2021-10-01 Downgrade Maxim Group Buy → Hold
2021-10-01 Downgrade Wedbush Neutral → Underperform
2021-09-27 Iniziato JP Morgan Neutral
2021-02-01 Iniziato UBS Buy
2020-10-20 Iniziato BofA Securities Buy
2020-08-21 Reiterato H.C. Wainwright Buy
2020-08-14 Reiterato Maxim Group Buy
2019-05-06 Iniziato Cantor Fitzgerald Overweight
2018-07-12 Iniziato Seaport Global Securities Buy
2018-03-23 Downgrade Wedbush Outperform → Neutral
2018-03-05 Downgrade Needham Buy → Hold
2017-11-08 Iniziato H.C. Wainwright Buy
2017-05-11 Downgrade Cantor Fitzgerald Buy → Neutral
2017-03-17 Reiterato Maxim Group Buy
2017-03-17 Reiterato Needham Buy
2016-11-16 Reiterato Wedbush Outperform
2016-11-10 Reiterato Needham Buy
2016-08-10 Reiterato Maxim Group Buy
2016-06-03 Iniziato Cantor Fitzgerald Buy
2016-03-02 Reiterato Needham Buy
2016-02-29 Reiterato Wedbush Outperform
2015-11-11 Reiterato Needham Buy
2015-08-18 Reiterato WBB Securities Strong Buy
2015-08-10 Iniziato ROTH Capital Buy
Mostra tutto

Omeros Corporation Borsa (OMER) Ultime notizie

pulisher
Jul 24, 2025

What analysts say about Omeros Corporation stockExceptional profit potential - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Omeros Corporation Stock Analysis and ForecastPhenomenal trading returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Omeros Corporation stock priceStrongest growth potential - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Why Omeros Corporation stock attracts strong analyst attentionAnalyst Grade Signals - Newser

Jul 22, 2025
pulisher
Jul 20, 2025

Is Omeros Corporation a good long term investmentSky-high profits - PrintWeekIndia

Jul 20, 2025
pulisher
Jul 19, 2025

How Omeros Corporation stock performs during market volatilityStrategic High Profit Opportunities - beatles.ru

Jul 19, 2025
pulisher
Jul 17, 2025

what makes omeros corporation stock price move sharplyFree Access to Community - Newser

Jul 17, 2025
pulisher
Jul 16, 2025

FY2027 Earnings Forecast for Omeros Issued By HC Wainwright - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Omeros Corporation stock price move sharplyWatchlist Winner Update - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Omeros Corporation (NASDAQ:OMER) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Jul 11, 2025
pulisher
Jul 07, 2025

Omeros gets FDA acceptance for narsoplimab BLA resubmission - MSN

Jul 07, 2025
pulisher
Jul 05, 2025

Wealth Enhancement Advisory Services LLC Takes $579,000 Position in Omeros Corporation (NASDAQ:OMER) - Defense World

Jul 05, 2025
pulisher
Jul 04, 2025

Omeros Seeks EMA Approval For Narsoplimab After Data Shows 3X Survival Boost - MSN

Jul 04, 2025
pulisher
Jul 03, 2025

Both retail investors who control a good portion of Omeros Corporation (NASDAQ:OMER) along with institutions must be dismayed after last week's 12% decrease - simplywall.st

Jul 03, 2025
pulisher
Jul 02, 2025

Omeros shareholders elect directors and approve executive pay at annual meeting - Investing.com

Jul 02, 2025
pulisher
Jun 30, 2025

Omeros stock maintains Buy rating at H.C. Wainwright on EU submission - Investing.com

Jun 30, 2025
pulisher
Jun 28, 2025

Omeros (NASDAQ:OMER) Downgraded by Wall Street Zen to “Sell” - Defense World

Jun 28, 2025
pulisher
Jun 27, 2025

Omeros' Narsoplimab: A Lifeline for TA-TMA Patients and a Regulatory Crossroads - AInvest

Jun 27, 2025
pulisher
Jun 27, 2025

Omeros Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency for the Treatment of TA-TMA | OMER Stock News - GuruFocus

Jun 27, 2025
pulisher
Jun 27, 2025

Omeros (OMER) Eyes European Approval for Key Drug Narsoplimab | OMER Stock News - GuruFocus

Jun 27, 2025
pulisher
Jun 24, 2025

Omeros Announces Webcast Details for Annual Meeting of Shareholders - FinancialContent

Jun 24, 2025
pulisher
Jun 16, 2025

Ratios Revealed: Decoding Omeros Corporation (OMER)’s Financial Health - DWinneX

Jun 16, 2025
pulisher
Jun 16, 2025

Omeros Co. (NASDAQ:OMER) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Jun 16, 2025
pulisher
Jun 13, 2025

What is HC Wainwright’s Forecast for Omeros FY2025 Earnings? - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

HC Wainwright Predicts Omeros’ Q2 Earnings (NASDAQ:OMER) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Omeros (NASDAQ:OMER) Now Covered by Analysts at HC Wainwright - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Comments on Omeros FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Omeros Analyst Sees $1 Billion Potential For Narsoplimab Before FDA Decision - Benzinga

Jun 10, 2025
pulisher
Jun 10, 2025

Trend Tracker for (OMER) - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 10, 2025

Omeros (OMER) Receives Buy Rating from HC Wainwright & Co. | OME - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Omeros (OMER) Receives Buy Rating from HC Wainwright & Co. | OMER Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

HC Wainwright Initiates Coverage on Omeros With Buy Rating, $9 Price Target - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Omeros (OMER) Set for Growth with Potential Narsoplimab Approval - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Omeros (OMER) Set for Growth with Potential Narsoplimab Approval | OMER Stock News - GuruFocus

Jun 10, 2025

Omeros Corporation Azioni (OMER) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):